tetano
Editor, Senior Moderator
Acta Diabetol
. 2021 Mar 20.
doi: 10.1007/s00592-021-01701-1. Online ahead of print.
Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis
Halla Kaminska[SUP] 1 [/SUP], Lukasz Szarpak[SUP] 2 3 [/SUP], Dariusz Kosior[SUP] 4 5 [/SUP], Wojciech Wieczorek[SUP] 6 [/SUP], Agnieszka Szarpak[SUP] 7 [/SUP], Mahdi Al-Jeabory[SUP] 8 [/SUP], Wladyslaw Gawel[SUP] 9 [/SUP], Aleksandra Gasecka[SUP] 10 11 12 [/SUP], Milosz J Jaguszewski[SUP] 13 [/SUP], Przemyslawa Jarosz-Chobot[SUP] 1 [/SUP]
Affiliations
Abstract
Background: The novel coronavirus disease 2019 (COVID-19) has spread worldwide since the beginning of 2020, placing the heavy burden on the health systems all over the world. The population that particularly has been affected by the pandemic is the group of patients suffering from diabetes mellitus. Having taken the public health in considerations, we have decided to perform a systematic review and meta-analysis of diabetes mellitus on in-hospital mortality in patients with COVID-19.
Methods: A systematic literature review (MEDLINE, EMBASE, Web of Science, Scopus, Cochrane) including all published clinical trials or observational studies published till December 10, 2020, was performed using following terms "diabetes mellitus" OR "diabetes" OR "DM" AND "survival" OR "mortality" AND "SARS-CoV-2" OR "COVID-19".
Results: Nineteen studies were included out of the 7327 initially identified studies. Mortality of DM patients vs non-DM patients was 21.3 versus 6.1%, respectively (OR = 2.39; 95%CI: 1.65, 3.64; P < 0.001), while severe disease in DM and non-DM group varied and amounted to 34.8% versus 22.8% (OR = 1.43; 95%CI: 0.82, 2.50; P = 0.20). In the DM group, the complications were observed far more often when compared with non-DM group, both in acute respiratory distress (31.4 vs. 17.2%; OR = 2.38; 95%CI:1.80, 3.13; P < 0.001), acute cardiac injury (22.0% vs. 12.8%; OR = 2.59; 95%CI: 1.81, 3.73; P < 0.001), and acute kidney injury (19.1 vs. 10.2%; OR = 1.97; 95%CI: 1.36, 2.85; P < 0.001).
Conclusions: Based on the findings, we shall conclude that diabetes is an independent risk factor of the severity of COVID-19 in-hospital settings; therefore, patients with diabetes shall aim to reduce the exposure to the potential infection of COVID-19.
Keywords: COVID-19; Diabetes mellitus; Hospitalization; Meta-analysis; Mortality; SARS-CoV-2; Systematic review.
. 2021 Mar 20.
doi: 10.1007/s00592-021-01701-1. Online ahead of print.
Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis
Halla Kaminska[SUP] 1 [/SUP], Lukasz Szarpak[SUP] 2 3 [/SUP], Dariusz Kosior[SUP] 4 5 [/SUP], Wojciech Wieczorek[SUP] 6 [/SUP], Agnieszka Szarpak[SUP] 7 [/SUP], Mahdi Al-Jeabory[SUP] 8 [/SUP], Wladyslaw Gawel[SUP] 9 [/SUP], Aleksandra Gasecka[SUP] 10 11 12 [/SUP], Milosz J Jaguszewski[SUP] 13 [/SUP], Przemyslawa Jarosz-Chobot[SUP] 1 [/SUP]
Affiliations
- PMID: 33778910
- DOI: 10.1007/s00592-021-01701-1
Abstract
Background: The novel coronavirus disease 2019 (COVID-19) has spread worldwide since the beginning of 2020, placing the heavy burden on the health systems all over the world. The population that particularly has been affected by the pandemic is the group of patients suffering from diabetes mellitus. Having taken the public health in considerations, we have decided to perform a systematic review and meta-analysis of diabetes mellitus on in-hospital mortality in patients with COVID-19.
Methods: A systematic literature review (MEDLINE, EMBASE, Web of Science, Scopus, Cochrane) including all published clinical trials or observational studies published till December 10, 2020, was performed using following terms "diabetes mellitus" OR "diabetes" OR "DM" AND "survival" OR "mortality" AND "SARS-CoV-2" OR "COVID-19".
Results: Nineteen studies were included out of the 7327 initially identified studies. Mortality of DM patients vs non-DM patients was 21.3 versus 6.1%, respectively (OR = 2.39; 95%CI: 1.65, 3.64; P < 0.001), while severe disease in DM and non-DM group varied and amounted to 34.8% versus 22.8% (OR = 1.43; 95%CI: 0.82, 2.50; P = 0.20). In the DM group, the complications were observed far more often when compared with non-DM group, both in acute respiratory distress (31.4 vs. 17.2%; OR = 2.38; 95%CI:1.80, 3.13; P < 0.001), acute cardiac injury (22.0% vs. 12.8%; OR = 2.59; 95%CI: 1.81, 3.73; P < 0.001), and acute kidney injury (19.1 vs. 10.2%; OR = 1.97; 95%CI: 1.36, 2.85; P < 0.001).
Conclusions: Based on the findings, we shall conclude that diabetes is an independent risk factor of the severity of COVID-19 in-hospital settings; therefore, patients with diabetes shall aim to reduce the exposure to the potential infection of COVID-19.
Keywords: COVID-19; Diabetes mellitus; Hospitalization; Meta-analysis; Mortality; SARS-CoV-2; Systematic review.